Abstract:Objective-To assess the frequency and type of side effects after influenza vaccination in elderly people.Design-Randomised double blind placebo controlled study.Setting-15 general practices in the southern Netherlands.Subjects-1806 patients aged 60 or older, of whom 904 received influenza vaccine and 902 placebo.Main outcome measures-Adverse reactions reported on postal questionnaire completed four weeks after vaccination.Results-210 (23%) patients given vaccine reported one or more adverse reactions compared … Show more
“…Systemic symptoms or disability are seen as often in persons receiving placebo as in those who have received inactivated influenza vaccine. Mild local reactions, such as a ''sore arm'', are less common after placebo than after active substance, 5-10% versus 15-20%, respectively [265][266][267]. The inactivated vaccine is also safe to administer to patients with asthma, including those with severe asthma [268].…”
“…Systemic symptoms or disability are seen as often in persons receiving placebo as in those who have received inactivated influenza vaccine. Mild local reactions, such as a ''sore arm'', are less common after placebo than after active substance, 5-10% versus 15-20%, respectively [265][266][267]. The inactivated vaccine is also safe to administer to patients with asthma, including those with severe asthma [268].…”
“…In a randomized, double-blind, crossover trial in the elderly, Margolis and colleagues 57 reported no significant systemic symptoms. In another randomized clinical trial, Govaert et al 58 found no increase in systemic adverse reactions, only an increase in local side effects.…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.